Innospec (IOSP) Common Equity (2010 - 2026)

Innospec (IOSP) has 17 years of Common Equity data on file, last reported at $1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 6.83% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 6.83% YoY), and the FY2025 full-year result was $1.3 billion, up 9.05% from the prior year.
• Common Equity improved to $1.4 billion in Q1 2026, from $1.3 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.4 billion in Q1 2026 to a low of $1.0 billion in Q4 2022.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Common Equity.
• Peak annual rise in Common Equity reached 11.45% in 2022, while the deepest fall reached 0.72% in 2022.
• Tracing IOSP's Common Equity over 5 years: stood at $1.0 billion in 2022, then advanced by 10.5% to $1.1 billion in 2023, then gained by 5.78% to $1.2 billion in 2024, then advanced by 9.05% to $1.3 billion in 2025, then gained by 1.97% to $1.4 billion in 2026.
• Business Quant data shows IOSP's Common Equity at $1.4 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.